首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Blockade of the passive cell death pathway does not prevent tolerance induction to islet grafts.
【24h】

Blockade of the passive cell death pathway does not prevent tolerance induction to islet grafts.

机译:被动细胞死亡途径的阻断不能阻止对胰岛移植物的耐受性诱导。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: T-cell apoptosis is an important regulatory mechanism in transplant tolerance. The aim of this study was to identify specific apoptotic molecules important for tolerance induction. METHODS: Mice expressing the human Bcl-2 molecule in T cells or Bim -/- mice were used as islet allograft or rat islet xenograft recipients and treated with CTLA4-Fc and MR1 costimulation blockade. RESULTS: hBcl-2 transgenic mice and Bim -/- accepted islet allografts and rat islet xenografts for more than 100 days, similar to wildtype controls. Changes in the dose of the CTLA4-Fc and MR1 did not lead to differences in graft survival and there were no differences in the percentage of CD4+ T cells expressing Fas, CD25, or undergoing apoptosis. CONCLUSIONS: Inhibition of the passive cell death pathway in T cells did not block tolerance induction, suggesting that the mechanism by which apoptosis regulates the alloimmune response is more complex than first thought.
机译:背景:T细胞凋亡是移植耐受的重要调控机制。这项研究的目的是确定对诱导耐受性重要的特定凋亡分子。方法:将在T细胞或Bim-/-小鼠中表达人Bcl-2分子的小鼠用作胰岛同种异体移植或大鼠胰岛异种移植受体,并用CTLA4-Fc和MR1共刺激阻断剂治疗。结果:与野生型对照相似,hBcl-2转基因小鼠和Bim-/-接受的胰岛同种异体移植和大鼠胰岛异种移植持续100天以上。 CTLA4-Fc和MR1剂量的变化不会导致移植物存活率的差异,表达Fas,CD25或正在发生凋亡的CD4 + T细胞的百分比也没有差异。结论:抑制T细胞中的被动细胞死亡途径并不能阻止耐受性诱导,这表明凋亡调节同种免疫反应的机制比最初的设想更为复杂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号